Results 131 to 140 of about 8,127 (213)

Ginsenoside Rb1 targets the NRF2-PPARγ-ACSL4 axis to inhibit PTECs ferroptosis. [PDF]

Chin Med
Tan B, Wu Z, Wang S, Tan W, Lin L, Yang X, Zheng L, Li J, Li K, Yang J, Li L.   +10 more
europepmc   +1 more source

Ginsenoside Rg5 Inhibits Succinate-Associated Lipolysis in Adipose Tissue and Prevents Muscle Insulin Resistance [PDF]

, 2017
Baolin Liu, Jia Li, Kang Liu, Le-Le Yang, Li-Wei Liu, Lian-Wen Qi, Na Xiao, Ping Li, Yi-Lin Yang   +8 more
core   +1 more source

Ginsenoside Rb1 alleviates endothelial dysfunction and vascular remodeling in preeclampsia via activation of the PI3K-Akt-eNOS pathway. [PDF]

Sci Rep
Jia W, Wang W, Zhang B, Wang C, Huang X.
europepmc   +1 more source

Gut microbiome and metabolome in aneurysm rat with hypertension after ginsenoside Rb1 treatment. [PDF]

Front Pharmacol, 2023
Zeng Z, Wang H, Yi R, Lou J, Wen S, Hu Z.   +5 more
europepmc   +1 more source

Ferulic acid in combination with ginsenoside Rb1 alleviates myocardial no-reflow by inhibiting platelet HMGB1 release and NET formation. [PDF]

Chin Med
Li J, You Y, Wang Y, Zou J, Xiao S, Yin X, Xu J, Liao F, Zhang H, You Y.   +9 more
europepmc   +1 more source

Pharmacological activation of SIRT1-AMPK by ginsenoside Rb1: a novel therapeutic strategy for pressure injury <i>via</i> dual suppression of ferroptosis and inflammation. [PDF]

Front Pharmacol
Zhu H, Li H, Shi Y, Zhi H, Zhao X, Wang Z, Liu J.   +6 more
europepmc   +1 more source

Preparation, characterization and in vivo pharmacokinetic study of ginsenoside Rb1-PLGA nanoparticles. [PDF]

Sci Rep, 2023
Du L, Lu H, Xiao Y, Guo Z, Li Y.
europepmc   +1 more source

Multi-omics analysis reveals that ginsenoside Rb1 improves prognostic outcomes in sepsis by modulating mitochondrial metabolism MTHFD2 targets. [PDF]

Sci Rep
Shu Q, Luo H, Zhong L, Mo J, Wei X, Zhu Z, Chen X, She H, He F, Zhu J.   +9 more
europepmc   +1 more source

Retraction Note: Attenuating effect of Ginsenoside Rb1 on LPS-induced lung injury in rats. [PDF]

J Inflamm (Lond), 2023
Yuan Q, Jiang YW, Ma TT, Fang QH, Pan L.
europepmc   +1 more source

Ginsenoside Rb1 Alleviated the AKI to CKD Transition by Targeting VEGFR2. [PDF]

J Cell Mol Med
Zhang K, Ji Y, Fu Z, Wang X, Zhang Y, Yang Y, Liu R, Chen X, Cai G, Hong Q.   +9 more
europepmc   +1 more source